Abstract In May 2019, the International Scientific Association for Probiotics and Prebiotics
(ISAPP) convened a panel of nutritionists, physiologists and microbiologists to review the …

Despite the successful development of new therapies for the treatment of type 2 diabetes,
such as glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose …

Purpose In this review, we summarize current evidence on the gut microbiome and microbial
metabolites in relation to obesity and obesity-associated metabolic disorders. Special …

Diabetes mellitus is a significant clinical and therapeutic problem because it can lead to
serious long-term complications. Its pathogenesis is not fully understood, but there are …

To summarize the microbiome's role in metabolic disorders (insulin resistance,
hyperglycemia, type 2 diabetes, obesity, hyperlipidemia, hypertension, nonalcoholic fatty …

Type 2 diabetes mellitus is the most prevalent metabolic disorder characterized by
hyperglycemia, hyperlipidemia as well as insulin resistance and is affecting the lives of a …

Purpose Compared to a healthy population, the gut microbiota in type 2 diabetes presents
with several unfavourable features that may impair glucose regulation. The aim of this study …

Mounting evidence suggested that the gut microbiota has a significant role in the
metabolism and disease status of the host. In particular, Type 2 Diabetes (T2D), which has a …

Alterations in the composition and function of the gut microbiota have been reported in
patients with type 2 diabetes mellitus (T2DM). Emerging studies show that prescribed …

Diabetes mellitus type 2 (T2DM) is associated with hyperglycemia, insulin resistance, and
gut dysbiosis. Probiotics and prebiotics can ameliorate T2DM through different mechanisms …